A new technic using polyethylene glycol (PEG) was developed to detect and enhance weak red blood cell/antibody reactions. Twenty percent PEG of 4,000 molecular weight was found to be optimal. Weakly reactive antibodies (n = 25) were tested by PEG, Polybrene®, and low ionic strength saline (LISS); 64% were strongest in PEG, 28% reacted equally in PEG as in Polybrene or LISS, 8% reacted weaker in PEG than in Polybrene or LISS. Stronger antibodies (n = 11) were titrated and compared in the three technics; in 10 of 11 titrations, PEG was better or equal to Polybrene and LISS. The false positive rate with the use of PEG and anti-IgG was 1.5% with the use of random sera. Sera from patients (n = 24) with hemolytic transfusion reactions and no detectable antibody by routine technics were tested; two sera had specific antibodies by the PEG technic. This new technic should be a valuable aid in the detection and identification of weak antibodies. (Key words: Polyethylene glycol (PEG); Immunohematology; RBC antigen-antibody reactions; Agglutination; Potentiators) Am J Clin Pathol 1987; 87: 633-635 POLYETHYLENE GLYCOL, (PEG) is a water-soluble polymer used extensively in industry as a lubricant for rubber molds, textile fibers, and ceramics, and in many other applications. PEG has been used for immunoglobulin precipitation and immune complex detection.
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Materials and Methods

Indirect PEG Procedure
Patients' or donors' sera (two drops) were mixed with one drop of 4% reagent or donors' RBCs and four drops of PEG solution. The optimal PEG solution was found to be of 4,000 molecular weight (Sigma Chemical Company, St. Louis, MO) at a 20% suspension in phosphatebuffered saline (PBS). The serum/PEG/RBC mixture was incubated at 37 °C for 15 minutes, then washed four times with PBS. It was important not to centrifuge after the 37 °C incubation because the presence of PEG made it difficult to resuspend the RBCs if they were centrifuged. After washing, anti-IgG was added and the tubes centrifuged at 1,000X g for 20 seconds. Appropriate weak positive and negative controls were always tested in parallel. The weak positive control is a dilution of anti-D that is nonreactive in low ionic strength saline (LISS) but is reactive in the PEG and Polybrene® technics.
Direct PEG Procedure
One drop 4% patient RBCs was added to each of two tubes. Two drops of 5% inert AB sera was added to one tube and two drops of patient's serum to the other. Four drops of PEG solution was added, mixed, and incubated at 37 °C for 15 minutes. The RBCs were washed four times with PBS; anti-IgG was added and the tubes centrifuged at 1,000X g for 20 seconds.
Other Serologic Methods
The serologic methods used in this study have been described previously. 2, 712 Titrations were scored by the method of Petz and Garratty. 
Enzyme-Linked Antiglobulin Test (ELAT)
This test was performed as described previously."
Results
Random sera from hospital patients (n = 104) and donors (n = 100), with no demonstrable antibodies by a LISS technic, were tested with PEG and Polybrene technics. We used anti-IgG throughout because initial tests with the use of polyspecific antihuman globulin yielded 14% nonspecific reactions by the PEG technic that were found to result from complement sensitization. All of the donor sera were negative by the PEG technic, but two were positive by Polybrene: of these, one antibody was identified as anti-M, and the other's specificity could not be determined. Four of the 104 random hospital patients' NANCE AND GARRATTY AJ.C.P.-May 1987 sera reacted by the PEG technic: 1 showed anti-Jk b specificity; the specificity of 2 sera could not be determined; and 1 was insufficient for further study. With the use of the Polybrene technic, seven patients' sera reacted, but either we were unable to identify the specificity of the antibodies or there was not sufficient volume for further studies.
Because we hoped that PEG could act as a potentiator of weak reactions, we tested 25 weak antibodies that were microscopically to 2+ reactive in a LISS technic at the antiglobulin phase of testing. The specificities included anti-D, -C, -E, -c, -e, -M, -S, -Fy (Table 1) . Sixteen (64%) reacted strongest by the PEG procedure; seven (28%) reacted equally by PEG, Polybrene, or LISS; two (8%) reacted weaker by the PEG procedure than with Polybrene or LISS. None of the antibodies tested were nonreactive by the PEG technic.
Eleven stronger antibodies were titrated, and master dilutions of each antibody were tested in parallel with (Table 2) .
Twenty-four cases of hemolytic transfusion reaction with no antibody detected by routine procedures 5 were tested by less common procedures (4% ficin capillary, Polybrene) and our new PEG technic. In one case, we were able to detect an anti-Jk a in PEG and Polybrene. In another case, an anti-e was detected by 4% ficin capillary, Polybrene, and PEG. The other 22 cases were negative by all technics.
Often patients who were suspected of having Coombsnegative autoimmune hemolytic anemia, and whose RBCs were sensitized with IgG that was only detectable by a direct ELAT, 4 only two had a positive direct PEG test. Two of the ten patients also had a positive direct Polybrene test. Discussion Several potentiating media have been described since albumin, 1 a recent example being Polybrene. 7 Our intitial experiences with PEG suggests it may be more sensitive than Polybrene and yield fewer false positive reactions.
When an anti-IgG was used, the incidence of false positive reactions associated with the indirect PEG technic was 0% with donor sera and 2.9% with sera from hospital patients, yielding a total false positive rate of 1.5%. This compared favorably with the false positive rate of 2.5% associated with Polybrene.
Sixty-four percent of weak antibodies were enhanced by PEG. Compared with Polybrene, significantly higher titration scores (differences of 10 or greater) were seen in 7 of 11 (64%) stronger antibodies when PEG was used, and in 10 of the 11 (91%) PEG had an equal or higher score. In comparing LISS with PEG, 6 of 11 (55%) antibodies showed significantly higher scores with PEG. Again, 10 of 11 antibodies gave equal or higher titration scores with PEG as compared with LISS.
The indirect PEG test was useful in detecting alloantibodies that had caused hemolytic transfusion reactions and were not detectable by routine procedures. We have previously described Polybrene and the 4% ficin capillary technics as also being useful in this area. 5 We do not know why such clinically significant antibodies are detectable by these unusual technics but not routine procedures, including the use of antiglobulin tests using enzyme-treated RBCs.
The direct PEG test was not as sensitive as the ELAT 4 " in detecting small amounts of RBC-bound IgG autoantibody in tests with RBCs from ten patients suspected of having Coombs-negative autoimmune hemolytic anemia. All the RBCs tested had negative direct antiglobulin tests but positive direct ELATs. Only two cases had positive direct PEG tests. Unfortunately, we were unable to obtain further samples from these two patients when they were in hematologic remission to determine if the results of the direct PEG test had become negative.
In summary, the indirect PEG technic enhanced the reactivities of most alloantibodies tested and detected two clinically significant antibodies not detectable by routine procedures. We do not suggest, at present, that this test should replace any of the commonly used procedures, but it may be useful as a supplementary test in the detection of weak antibodies. The PEG technic may also be useful in enhancing reactivity of weak, rare typing reagents, provided adequate quality control of test sera is performed.
The authors tested 15 immune serum globulin pharmaceutical preparations for antibody reactivity to human T cell lymphotrophic virus type HI (HTLV-III) by the Abbott® immunoenzymometric assay (IEMA). Although no evidence of HTLV-III infectivity has appeared after injection of similar preparations into humans, the authors found all samples IEMA reactive. Upon dilution, the authors demonstrated parallel decreases of antibody reactivity among two samples of gamma globulin, the Abbottpositive control, and a markedly reactive patient specimen.
